Search - tctmd.com

Displaying 1 - 20 of 483

Sort: Relevancy | Date

News Conference News TCT 2025

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

Yael L. Maxwell

November 07, 2025

News Conference News TCT 2025

SAVE-PCI: Small-Bore Percutaneous VAD Matches IABP in High-risk PCI

Caitlin E. Cox

November 06, 2025

News Conference News TCT 2025

‘Investing’ in CTOs With Staged PCI Seems to Pay Off in Safety Gains

Yael L. Maxwell

November 05, 2025

News Conference News TCT 2025

AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations

Todd Neale

October 31, 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

News Conference News TCT 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Yael L. Maxwell

October 28, 2025

News Conference News TCT 2025

Tailored Testing and Care Ease Angina for MINOCA Patients: PROMISE

Caitlin E. Cox

October 28, 2025

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

Presentation TCT 2025

Should Sham Control vs Open Trial Design Make a Difference for Device Regulators and Guideline Makers?

Presenter: Gregg W. Stone

October 28, 2025

News Conference News TCT 2025

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Caitlin E. Cox

October 27, 2025

Presentation TCT 2025

Can Adaptive and Single-Arm Studies Meet the Needs of Key Stakeholders?

Presenter: Rasha Al-Lamee

October 27, 2025

Presentation TCT 2025

Case-Based Discussion: Designing a Contemporary Cardiovascular Trial

Presenter: Stephan Windecker

October 27, 2025

Presentation TCT 2025

Modifying the Win Ratio for Noninferiority Trials: A Bridge Too Far?

Presenter: Björn Redfors

October 27, 2025

Presentation TCT 2025

Is the WIN ratio always a “Winner”: Where It’s Useful, Where It’s Not

Presenter: John Gregson

October 27, 2025

Presentation TCT 2025

Adaptive and Sequential Designs: From Concept to Execution

Presenter: Graeme L. Hickey

October 27, 2025

Presentation TCT 2025

Smarter Trial Design: Using AI and Real-World Data for Protocol Modeling and Trial Feasibility

Presenter: Harun Kundi

October 27, 2025

Presentation TCT 2025

Non-Inferiority Trials – Bridge or Barrier to Patient-Centered Progress?

Presenter: Sanjay Kaul

October 27, 2025

Presentation TCT 2025

Subgroup Analyses in Non-Inferiority Studies: Signal or Noise?

Presenter: Björn Redfors

October 27, 2025

Presentation TCT 2025

How to Interpret a “Negative” Non-Inferiority Trial: Case-Based Discussion

Presenter: Donald Cutlip

October 27, 2025

Presentation TCT 2025

Sequential Superiority After Non-Inferiority: Opportunities and Risks

Presenter: Roseann M. White

October 27, 2025

Advertisement

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

SAVE-PCI: Small-Bore Percutaneous VAD Matches IABP in High-risk PCI

‘Investing’ in CTOs With Staged PCI Seems to Pay Off in Safety Gains

AI-ECG Finds STEMI Faster, Cuts False-Positive Cath Lab Activations

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Tailored Testing and Care Ease Angina for MINOCA Patients: PROMISE

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Should Sham Control vs Open Trial Design Make a Difference for Device Regulators and Guideline Makers?

PREVUE-VALVE Charts the Prevalence of Valve Disease in the United States

Can Adaptive and Single-Arm Studies Meet the Needs of Key Stakeholders?

Case-Based Discussion: Designing a Contemporary Cardiovascular Trial

Modifying the Win Ratio for Noninferiority Trials: A Bridge Too Far?

Is the WIN ratio always a “Winner”: Where It’s Useful, Where It’s Not

Adaptive and Sequential Designs: From Concept to Execution

Smarter Trial Design: Using AI and Real-World Data for Protocol Modeling and Trial Feasibility

Non-Inferiority Trials – Bridge or Barrier to Patient-Centered Progress?

Subgroup Analyses in Non-Inferiority Studies: Signal or Noise?

How to Interpret a “Negative” Non-Inferiority Trial: Case-Based Discussion

Sequential Superiority After Non-Inferiority: Opportunities and Risks

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content